Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syncytial Virus Respiratory Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02561871
What this trial is testing

Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers

Who this might be right for
Respiratory Syncytial VirusesRespiratory Tract Infections
Crucell Holland BV 34
Early research (Phase 1)Study completedNCT03384823
What this trial is testing

EDP-938 in Healthy Subjects

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 90
Not applicableEnded earlyNCT01757496
What this trial is testing

Cough Assist in Bronchiolitis

Who this might be right for
BronchiolitisRespiratory Syncytial Virus
University Hospital, Antwerp 1
Not applicableStudy completedNCT03614676
What this trial is testing

Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 4,493
Not applicableUnknownNCT05562817
What this trial is testing

The Epidemiology , Health and Economic Burden of RSV Amongst Hospitalized Children Under 5 Years of Age in Jordan

Who this might be right for
Respiratory Syncytial Virus Infections
MENA Center for Research & Development and Internship 1,200
Early research (Phase 1)Ended earlyNCT02948127
What this trial is testing

Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 8
Testing effectiveness (Phase 2)Study completedNCT04068792
What this trial is testing

A Two-Part Infant Study for Early Diagnosis of Respiratory Syncytial Virus (RSV) and Evaluation of JNJ-53718678 in RSV Acute Respiratory Tract Disease

Who this might be right for
Respiratory Syncytial Viruses
Janssen Research & Development, LLC 22
Testing effectiveness (Phase 2)Study completedNCT04138056
What this trial is testing

A Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 509
Not applicableUnknownNCT06259487
What this trial is testing

Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.

Who this might be right for
Heart FailureRSV InfectionInfluenza+1 more
Wroclaw Medical University 250
Early research (Phase 1)Study completedNCT01906164
What this trial is testing

Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers

Who this might be right for
Respiratory Syncytial Virus Infections
Alios Biopharma Inc. 101
Large-scale testing (Phase 3)Study completedNCT04767373
What this trial is testing

Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)

Who this might be right for
Respiratory Syncytial Virus Infection
Merck Sharp & Dohme LLC 3,632
Early research (Phase 1)Ended earlyNCT01475305
What this trial is testing

Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV)

Who this might be right for
RSV Infection
MedImmune LLC 7
Early research (Phase 1)Active Not RecruitingNCT04896853
What this trial is testing

Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeInfluenza AMetapneumovirus Pneumonia+1 more
NextCell Pharma Ab 9
Testing effectiveness (Phase 2)Looking for participantsNCT06665100
What this trial is testing

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Who this might be right for
Hematologic MalignanciesHematopoietic Stem Cell Transplant (HSCT)
Pulmotect, Inc. 100
Large-scale testing (Phase 3)Study completedNCT00129766
What this trial is testing

Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 6,635
Not applicableStudy completedNCT01537198
What this trial is testing

Surveillance of Synagis in Korean Pediatric Patients

Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie (prior sponsor, Abbott) 618
Early research (Phase 1)Study completedNCT04528719
What this trial is testing

A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 651
Testing effectiveness (Phase 2)Study completedNCT04690335
What this trial is testing

Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine

Who this might be right for
RSV Infection
Meissa Vaccines, Inc. 60
Not applicableStudy completedNCT01107535
What this trial is testing

Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus Infection
Abbott 82
Large-scale testing (Phase 3)Study completedNCT06614725
What this trial is testing

A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 751
Next Page